Sciatic nerve stimulation alleviates acute neuropathic pain via modulation of neuroinflammation and descending pain inhibition in a rodent model
Journal of Neuroinflammation volume 19, Article number: 153 (2022)
Neuropathic pain (NP) is characterized by abnormal activation of pain conducting pathways and manifests as mechanical allodynia and thermal hypersensitivity. Peripheral nerve stimulation is used for treatment of medically refractory chronic NP and has been shown to reduce neuroinflammation. However, whether sciatic nerve stimulation (SNS) is of therapeutic benefit to NP remains unclear. Moreover, the optimal frequency for SNS is unknown. To address this research gap, we investigated the effect of SNS in an acute NP rodent model.
Rats with right L5 nerve root ligation (NRL) or Sham surgery were used. Ipsilateral SNS was performed at 2 Hz, 20 Hz, and 60 Hz frequencies. Behavioral tests were performed to assess pain and thermal hypersensitivity before and after NRL and SNS. Expression of inflammatory proteins in the L5 spinal cord and the immunohistochemical alterations of spinal cord astrocytes and microglia were examined on post-injury day 7 (PID7) following NRL and SNS. The involvement of the descending pain modulatory pathway was also investigated.
Following NRL, the rats showed a decreased pain threshold and latency on the von Frey and Hargreaves tests. The immunofluorescence results indicated hyperactivation of superficial spinal cord dorsal horn (SCDH) neurons. Both 2-Hz and 20-Hz SNS alleviated pain behavior and hyperactivation of SCDH neurons. On PID7, NRL resulted in elevated expression of spinal cord inflammatory proteins including NF-κB, TNF-α, IL-1β, and IL-6, which was mitigated by 2-Hz and 20-Hz SNS. Furthermore, 2-Hz and 20-Hz SNS suppressed the activation of spinal cord astrocytes and microglia following NRL on PID7. Activity of the descending serotoninergic pain modulation pathway showed an increase early on PID1 following 2-Hz and 20-Hz SNS.
Our results support that both 2-Hz and 20-Hz SNS can alleviate NP behaviors and hyperactivation of pain conducting pathways. We showed that SNS regulates neuroinflammation and reduces inflammatory protein expression, astrocytic gliosis, and microglia activation. During the early post-injury period, SNS also facilitates the descending pain modulatory pathway. Taken together, these findings support the therapeutic potential of SNS for acute NP.
Neuropathic pain (NP), defined as pain caused by a primary lesion of the nervous system, is characterized by abnormal activation of pain conducting pathways . Mechanical allodynia and thermal hypersensitivity are commonly observed in patients with NP and animal models of NP, including rats with L5 nerve root ligation (NRL) [2, 3].
Dysregulated pain signaling and modulation in the central nervous system (CNS) play a critical role in NP [1, 4]. The pathogenesis of NP following NRL is characterized by neuroinflammation in the spinal cord dorsal horn (SCDH) at the corresponding level [5, 6]. Injury of the sciatic nerve has been shown to induce proliferation and hypertrophy of spinal cord astrocytes via activation of the mitogen-activated protein kinase signaling pathway . Activation of extracellular signal-regulated kinase in spinal microglia and astrocytes following spinal nerve injury has also been reported . Such changes in spinal cord glial cells are known to facilitate hyperactivation of somatosensory neurons in the SCDH and result in NP [8,9,10]. Together, these findings suggest a pivotal role of CNS neuroinflammation in the development of acute pain hypersensitivity and the subsequent transition from acute to chronic NP. Thus, modulation of CNS neuroinflammation and the associated hyperactivation of somatosensory pain signaling pathways is a potential treatment strategy for alleviating NP.
Neuromodulatory techniques, such as peripheral nerve stimulation (PNS) and spinal cord stimulation, have been used to treat debilitating pain in patients who fail to respond to or cannot tolerate pharmacological treatments . Emerging clinical evidence supports the clinical efficacy of PNS in the management of chronic pain. Sator-Katzenschlager et al. reported a reduction in pain scores of more than 50% and a decrease in the doses of required analgesics in 111 NP patients receiving PNS . Similar results were obtained in patients with chronic back pain, who had lower pain scores and analgesic consumption after PNS [13, 14]. Goebel et al. successfully utilized PNS to achieve sustained pain relief in an amputated patient with complex regional pain syndrome who had failed to respond to SCS . Despite such evidence of PNS being successfully used to treat chronic pain, its applications in treating acute pain were not reported until recent years . For example, Ilfield et al. applied PNS in the immediate postoperative period following knee surgery and reported an average 85% improvement of pain scores .
Previous animal experiments have demonstrated that PNS can increase the pain threshold in NRL rats  and shed light on potential mechanisms of PNS, such as gate-control-induced paresthesia , inflammatory modulation [20, 21], and endogenous pain inhibition pathways . However, a detailed investigation of the mechanism of PNS is lacking. Furthermore, there is limited research on the frequency used in PNS, which is an imperative parameter affecting the response. PNS at a frequency of 100–10,000 Hz is associated with gate-control-induced paresthesia to achieve analgesia [19, 22], whereas PNS at a lower frequency (2–30 Hz) is reported to have a modulatory effect on inflammation [21, 23]. Thus, further investigation of frequency is essential for achieving optimal pain relief from PNS. Moreover, the existing studies regarding PNS in the treatment of acute pain conditions are limited to nociceptive pain, such as postoperative pain [17, 24]. The efficacy of PNS for acute NP is yet to be investigated.
To address these knowledge gaps in NP research, the present study aimed to elucidate the potential role of sciatic nerve stimulation (SNS) with graded frequency in an acute NP model of NRL rats. Three different electrical stimulation frequencies, namely 2 Hz, 20 Hz, 60 Hz, were compared in terms of their analgesic efficacy and their effects on histomorphology in the SCDH and pain-related regions of the brainstem.
This study was approved by the Animal Ethics Committee of National Cheng Kung University (NCKU) in Tainan, Taiwan (IACUC approval number: 109195). All surgical interventions, perioperative care, and treatments were performed in accordance with the guidelines of the Institute of Animal Use and Care Committee at NCKU. Adult male Sprague-Dawley rats (250–300 g) were obtained from BioLASCO (Nangang, Taipei, Taiwan) and housed at 25 ± 2 °C under a 12 h light–dark cycle. Food and water were available ad libitum. Efforts were made to reduce the number of animals used and to minimize animal suffering.
L5 spinal nerve root ligation model
The surgical procedures for L5 nerve root ligation (NRL) were performed as previously described with some modifications . The rats were anesthetized by an intraperitoneal injection of Zoletil® 50 (40 mg/kg; Virbac, Carros, France), administrated with enrofloxacin (5 mg/kg, Bayer, Leverkusen, Germany) and placed in a prone position. In brief, the paraspinal muscles were split via a paramedian incision and gently retracted to expose the L5 transverse process. The L5 transverse process was then removed to expose the underlying L5 nerve root. L5 spinal nerve ligation was performed with a 4–0 non-absorbable suture (Additional file 1: Supplementary figure 1). Wound closure was performed in a layer-by-layer fashion. After NRL, a heating pad was used to maintain the rat’s body temperature at 37 °C until recovery from anesthesia.
Sciatic nerve electrical stimulation
Five different sets of animal experiments, including SNS at three frequencies, were performed (Fig. 1): Sham (exposure of L5 nerve root without ligation, N = 10); NRL + Sham electrical stimulation (NRL + SES, N = 10); NRL + 2 Hz SNS (NRL + 2 Hz, N = 10); NRL + 20 Hz SNS (NRL + 20 Hz, N = 10); and NRL + 60 Hz SNS (NRL + 60 Hz, N = 10). SNS was performed in a 1-h single session starting 2 h after the surgery of L5 NRL. The segment of the stimulated sciatic nerve is ipsilateral to the ligated L5 nerve root at a location distal to the joint of L4, L5, and L6 nerve roots in the thigh. The electric stimulation was delivered via custom-made bipolar electrodes connected to a nerve conduction/electromyography stimulator (ISIS Xpress, inomed Medizintechnik Gmbh, Germany). The delivered stimulus consisted of 2-s-long uniform biphasic pulse trains at a frequency of 2 Hz, 20 Hz, and 60 Hz with 200-μs square wave pulses. The pulse trains were separated by 8-s off intervals. The intensity ranged from 1 to 10 mA. Motor responses were used to confirm the delivery of electric stimulation. The stimulation intensity was subsequently selected as the maximal intensity that did not trigger a motor response. These parameters were adapted from previous studies demonstrating that such stimuli activate all fiber types . In the NRL + SES group, Sham electrodes without electrical current were applied to the sciatic nerve.
Starting three days before surgery, the rats were introduced to the testing environment daily to allow for acclimation. The rats were placed in the environment used for the mechanical and thermal tests for 30 min before the tests were performed. Before and 1, 3, 5, and 7 days after surgery, the plantar surface of both ipsilateral and contralateral hind paws was probed using electrical von Frey tips (BIO-EVF5, Bioseb, France) to measure the thresholds of mechanical touch sensitivity (von Frey test). The tip was gently applied upward onto the rat’s middle plantar surface and force was slowly exerted until the rats withdrew, flicked, or licked their paw. The reading of the largest force (in grams) was automatically recorded. Each rat was tested five times separated by 15-s intervals.
Hargreaves test was performed on preoperative day 1 and 1, 3, 5, and 7 days after surgery to evaluate thermal sensitivity using a Plantar Test Apparatus (Ugo Basile, Comerio, Italy). An infrared heat source (50 W) was adjusted so that naïve rats had withdrawal latencies of 9–12 s. The heat source was focused on the plantar surface of the ipsilateral and contralateral hind paw and the time taken to withdraw from the heat stimulus was recorded. Each hind paw was tested three times separated by intervals of 2 min.
Western blot analysis
L4–L6 spinal cords were freshly collected and homogenized with T-PER reagent buffer containing protease inhibitor mixture (Thermo Scientific). Homogenates were centrifuged at 12,000 rpm for 15 min at 4 °C and the supernatants were collected as total cell lysates. Proteins extracts (30 μg), which were quantified using a protein assay kit (Micro BCA™, Thermo Fisher Scientific Inc.), were resuspended in loading buffer and subjected to polyacrylamide gel electrophoresis followed by transfer to a nitrocellulose membrane for 2 h. The membranes were blocked with 5% non-fat milk in Tris-buffered saline with Tween-20 (TBST, 20 mM Tris base, 130 mM NaCl, 0.1% Tween-20) and then incubated overnight at 4 °C with the following primary antibodies: anti-α-tubulin (GeneTex GTX112141, 1:10,000), anti- NF-κB (Cell Signaling Technology #8242, 1:2000), anti-IL-1β (Origene TA321162, 1:2000), anti-TNF-α (abcam ab6671, 1:2000), and anti-IL-6 (abcam ab6672, 1:2000). After primary antibody incubation, the membranes were washed with TBST and incubated with horseradish peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch Inc., West Grove, PA, USA) for 1 h at room temperature. Following the final washing step, Western blot analysis was performed using an enhanced chemiluminescence detection kit (WBKLS000, MerckMillipore/Merck KGaA) and visualized using a luminescence imaging system (Azure Biosystems). The protein level was normalized to α-tubulin and analyzed using ImageJ software (NIH, USA). All described experiments were performed in triplicate.
After the rats were anesthetized, transcardial perfusion was performed using ice-cold normal saline followed by 4% paraformaldehyde in 0.1 M phosphate buffer at pH 7.4. Spinal cord tissues were collected and postfixed in 4% paraformaldehyde at 4 °C overnight. Afterward, the spinal cord tissues were dissected into 10 mm segments, centered over the L5 level, immersed in PBS with 30% sucrose for cryoprotection at room temperature for 48 h, and embedded in optimal cutting temperature compound in liquid nitrogen. Transverse cryosections of the spinal cord and brainstem tissues were cut at 20 μm using a cryostat (LEICA CM1950) at − 20 °C. Ten sections at intervals of 480 μm were sampled from each animal for further immunofluorescence analysis.
Prior to immunofluorescence staining, sections were rinsed with 0.01 M phosphate-buffered saline (PBS), permeabilized, blocked with 2% normal goat serum (prepared in PBS supplemented with 0.1% BSA and 0.1% Triton X-100) for 5 min, and blocked with 10% normal goat serum (prepared in PBS supplemented with 0.1% BSA and 0.1% Triton X-100) for 20 min. The sections were then incubated overnight at 4 °C with the following primary antibodies: anti-c-fos (Abcam ab190289, 1:1000), anti-GFAP (Sigma G3893, 1:400), anti-Iba1 (GeneTex GTX635363, 1:200), and anti-TPH2 (Abcam ab211528, 1:500). This was followed by incubation with secondary fluorescent-dye conjugated secondary antibodies (Thermo Fisher Scientific Inc.) at room temperature for 1 h. After rinsing with 0.01 M PBS, the sections were mounted with media with 4′,6-diamidino-2-phenylindole (Abcam, Cambridge, UK). The fluorescent images were captured using a fluorescence microscopy system (Nikon M568E; Minato City, Tokyo, Japan). All described experiments were performed in triplicate.
Continuous variables were expressed as the mean ± standard deviation. Data from two groups were compared using Student’s t-test. Data from three or more groups were compared using one-way analysis of variance with Bonferroni’s post hoc test. Differences were considered statistically significant at p < 0.05.
SNS alleviates pain and thermal hypersensitivity in L5 NRL rats
To evaluate the effect of SNS, we first evaluated mechanical (von Frey test) and thermal (Hargreaves test) pain sensitivity in L5 NRL rats. The Sham group with the L5 root exposed but not ligated was used as a control. Compared to the Sham group, NRL + SES rats exhibited a significantly lower paw withdrawal threshold and decreased paw withdrawal latency from post-injury day 1 (PID1) to PID7 on the ipsilateral side (Fig. 2a, b) but not the contralateral side (Fig. 2c, d). To further investigate the therapeutic potential of SNS and the efficacy of different electrical frequencies, the pain behaviors of SNS rats following 2 Hz, 20 Hz, and 60 Hz stimulation were evaluated. On PID1, all frequencies of SNS increased the paw withdrawal thresholds and latencies compared to NRL + SES. On PID 3, 5, and 7, increased paw withdrawal thresholds and latencies compared to NRL + SES were observed for 2-Hz and 20-Hz SNS, but not 60-Hz SNS (Fig. 2a, b). The pain and thermal sensitivities of the contralateral paw were unchanged (Fig. 2c, d). We then calculated the cumulative withdrawal thresholds and latencies for each rat (Fig. 2e–h). The results showed that L5 NRL resulted in significantly decreased ipsilateral cumulative withdrawal thresholds and latencies and that the decreases were ameliorated by 2-Hz and 20-Hz SNS, but not 60-Hz SNS.
Hyperactivation of SCDH superficial laminar neurons is normalized following SNS in L5 NRL rats
Based on the pain behavior test results, we wondered if the alterations in pain behavior were correlated with alterations in the neuronal activity of pain transmitting neurons. Therefore, we investigated the neuronal activity of L5 SCDH superficial laminar neurons.
Figure 3 presents the immunofluorescence images of frozen SCDH sections on PID1 and PID7. The border between the superficial and the deep laminae (dashed line) was established based on the difference in the heterogenic neuronal size characteristic of lamina IV versus the smaller cells characteristic of lamina III  (see magnification on the right in Fig. 3a). Co-staining of NeuN and c-fos is shown in Fig. 3b. Quantification of c-fos/NeuN co-localized neurons in the L5 SCDH superficial laminar revealed a 4.8 and 5.9-fold increase in the number of activated neurons on PID1 and PID7, respectively, in the NRL + SES group compared with the Sham group (Fig. 3c, d). On PID1, the numbers of activated superficial laminar neurons observed in 2 Hz, 20 Hz, and 60 Hz SNS groups were 62.7%, 72.8%, and 75.3% less, respectively, compared with NRL + SES group. Whereas on PID7, the numbers of activated superficial laminar neurons were 51.8%, 76.9%, and 42.0% less in 2 Hz, 20 Hz, and 60 Hz SNS groups, respectively, compared to NRL + SES. Comparison of the different SNS frequencies showed that 20-Hz SNS resulted in a greater decrease in the SCDH c-fos signal compared to 2 Hz and 60 Hz on PID7. In contrast, there was no difference among the results of 2-Hz, 20-Hz and 60-Hz SNS on PID1.
Modulatory effect of SNS on expression of spinal cord NF-κB, TNF-α, IL-1β, and IL-6 in L5 NRL rats
Previous studies have shown that neuroinflammation in the SCDH plays an essential role in the formation of NP in NRL animal models [6, 28]. Therefore, we investigated whether SNS impacted the inflammatory response in the SCDH after L5 NRL.
Expression of the inflammatory mediator NF-κB and proinflammatory cytokines TNF-α, IL-1β, and IL-6 on PID1 and PID7 were measured by Western blotting (Fig. 4). On PID1, the expression of IL-1β and IL-6 was significantly elevated by 2.2-fold and 1.4-fold, respectively, in the NRL + SES group compared to the Sham group. We also observed a trend of elevated expression of NF-κB and TNF-α on PID1, although it was not statistically significant (Fig. 4b). On PID7, the levels of spinal cord NF-κB, TNF-α, IL-1β, and IL-6 were all significantly elevated by 1.6-fold, 1.8-fold, 1.6-fold, and 1.7-fold in the NRL + SES group compared to the Sham group, respectively (Fig. 4c). On PID1, none of the SNS groups showed significant changes in the expression of spinal cord NF-κB, TNF-α, IL-1β, and IL-6 compared to NRL + SES (Fig. 4b). However, on PID7, we observed that 20-Hz SNS reduced the expression of TNF-α, 2-Hz and 20-Hz SNS reduced the expression of NF-κB, and all frequencies of SNS reduced the expression of IL-1β and IL-6 (Fig. 4c).
Effects of various SNS frequencies on astrocyte proliferation and microglia activation on PID7 in the SCDH in L5 NRL rats
Since spinal cord astrocytes and microglia are also involved in neuroinflammation and the formation of NP [29,30,31,32], we investigated whether astrocyte proliferation and microglia activation occurred in SCDH in the rat model of acute NP. Figure 5a shows the immunofluorescence staining results of GFAP in frozen SCDH sections on PID7. Quantification of ipsilateral GFAP signal in the L5 spinal cord (Fig. 5a, magnification) revealed a 4.9-fold increase in the GFAP area and a 4.1-fold increase in the GFAP integrated density in the NRL + SES group compared with the Sham group (Fig. 5b). Notably, the increased ipsilateral signal was ameliorated by 2-Hz and 20-Hz SNS, but by not 60-Hz SNS (Fig. 5b). The contralateral GFAP area and integrated density were not affected by L5 NRL and SNS (Fig. 5c).
We also analyzed the immunofluorescence signal for Iba1 in L5 SCDH (Fig. 6a). The results revealed a 2.3-fold increase in the ipsilateral Iba1 area and a 4.8-fold increase in the Iba-1 integrated density in the NRL + SES group compared with the Sham group (Fig. 6b). The increase in the ipsilateral Iba1 signal was mitigated by 2-Hz and 20-Hz SNS, but not 60-Hz SNS (Fig. 6b). On the contralateral side, the difference in the Iba1 area and integrated density were not significant among all groups (Fig. 5c).
Upregulation of TPH2+ neuronal activity in the rostral ventromedial medulla following SNS in L5 NRL rats
To investigate the potential involvement of additional pain modulatory pathways, we analyzed the activity of the periaqueductal gray matter–rostral ventromedial medulla (PAG–RVM) descending pain modulation pathway. Figure 7 shows the immunofluorescence staining results of frozen RVM sections on PID 1. Colocalization of c-fos and TPH2 indicated the presence of activated serotoninergic neurons (Fig. 7b). Quantification of c-fos+/TPH2+ cells in the raphe magnus (RMg) nucleus revealed a 1.9-fold and 3.2-fold increase of c-fos + /TPH2+ cells following 2-Hz and 20-Hz SNS, respectively, compared to the Sham group (Fig. 7c). The changes in c-fos + /TPH2+ signals in the NRL + SES and NRL + 60 Hz groups were not significant compared to the Sham group.
A detailed characterization of the effect of SNS on NP models will increase our understanding of the mechanism of PNS to help achieve optimal pain relief. Moreover, research focusing on acute NP conditions may help broaden the range of clinical applications of PNS to benefit more patients in need. The main contribution of this study is demonstrating the analgesic efficacy of 2-Hz and 20-Hz SNS by showing alleviated pain behaviors and reduced SCDH hyperactivation in L5 NRL rats. Our results suggest that SNS plays an important role in pain modulation by reducing spinal cord inflammatory proteins and glial cell activation. Moreover, we showed an early increase in the activity of descending pain inhibition following 2-Hz and 20-Hz SNS, which may act in combination with the anti-inflammatory effect to achieve analgesia.
L5 NRL is a well-established rodent model of chronic NP that exhibits both pain and thermal hypersensitivity [25, 33]. In this study, the behavioral experiments validated the acute NP rat model of L5 NRL by showing that mechanical and thermal hypersensitivity occurred early on PID1 and were maintained until PID7. Although acute NP is increasingly clinically recognized , experimental models of acute NP are limited compared to those of chronic NP. Przewłocka et al. utilized crushing injury of the sciatic nerve as a model of acute NP and showed the development of allodynia on PID2; however, that study included no histological or biochemical analyses to supplement the pain behavioral test results . In the current study, the behavioral phenotype of NP was supported by histological examination performed on both PID1 and PID7, revealing the hyperactivation of superficial laminar neurons in the SCDH, which are the major projection neurons in the spinothalamic tract.
In the present study, SNS was performed at three frequencies, namely 2 Hz, 20 Hz, and 60 Hz. Nerve stimulation at frequency in the range of 2–30 Hz is reported to exert an anti-inflammatory effect [36, 37]. Besides vagus nerve stimulation, which has already been approved for the treatment of systemic inflammatory cognitions , PNS on somatic nerves is reported to reduce inflammation [36, 39]. A study by Gürgen et al. demonstrated that perilesional transcutaneous electrical stimulation inhibited proinflammatory cytokines, including TNF-α, IL-1β, and IL-6, and improved wound healing . Tu et al. proposed that, following PNS on sacral nerves, afferent signals were transmitted to the brainstem and that the efferent anti-inflammatory output is transmitted by the vagus nerve . Despite recent reports of the use of SNS to treat chronic pain , whether SNS affects inflammation remains unclear. Notably, it has been reported that 60–100 Hz stimulation resulted in paresthesia of the innervated region and produced analgesic effects via the gate-control mechanism [42, 43]. As a result, a tingling sensation is not uncommon in patients receiving higher frequency stimulation .
In this study, the biochemical analyses were performed on PID1 and PID7. We sampled the tissues on PID1 to capture the analgesic effect that occurred early on PID1 in animal experiments. We investigated the morphologies on PID7 because it was reported that the first 7 days represent the developmental phase and the acute-to-chronic transition of NP . Our results showed that, on PID1, all three frequencies of SNS alleviated the pain and thermal hypersensitivity induced by L5 NRL. However, only 2-Hz and 20-Hz SNS showed sustained analgesia on PID 3, 5, and 7. SNS with 60 Hz frequency only achieved analgesia on PID1 and the effect gradually declined. Although suppression of hyperactivated superficial SCDH neurons was observed at all frequencies on PID7, 60-Hz SNS had a lower efficacy. It is probable that the magnitude of suppression of hyperactivated superficial SCDH neurons resulting from 60-Hz SNS was insufficient to achieve analgesia. Additionally, it was also reported that the effect of high-frequency PNS may decline over time due to habituation , which might contribute to the different analgetic efficacy observed between 2 Hz, 20 Hz, and 60 Hz on PID7. Taken together, these results suggest that the mechanism through which 2-Hz, 20-Hz, and 60-Hz SNS achieve anti-nociception on PID1 may not be the same.
In light of the anti-inflammatory potential of SNS [21, 36], we hypothesized that modulation of CNS neuroinflammation may contribute to the observed differences in the effects of different SNS frequencies. Therefore, we investigated the neuroinflammatory response following L5 NRL and SNS. In the case of peripheral nerve injury, local inflammation at the injury site is followed by a proximal inflammatory response in the spinal cord . Previous studies of peripheral nerve injury by Murphy et al. and Costigan et al. have revealed increased expression of proinflammatory cytokines, including TNFα, IL-1β, and IL-6, in the SCDH on PID7 after nerve injury and it is known that these cytokines are required for the development of pain [46, 47]. Consistent with those results, we demonstrated elevated expression of spinal cord IL-1β, IL-6, NF-κB, and TNF-α on day 7 after NRL. Our measurements of spinal cord inflammatory proteins showed that, although elevated expression of NF-κB and g TNF-α was not observed until PID7, increases in IL-1β and IL-6 expression occurred early on PID1. This result is compatible with a previous report that increased expression of IL-1β and IL-6 preceded TNF-α . Overall, these findings suggest that IL-1β and IL-6 may be key initiators of neuroinflammation in NP and are thus potential therapeutic targets in the early stage of NP .
Next, because glial cells in the CNS are recognized as a major source of intrathecal IL-1β, IL-6, and TNFα , we investigated astrocyte proliferation and microglia activation in the SCDH following L5 NRL. Our results demonstrated astrocyte proliferation and microglia activation in the ipsilateral spinal cord on PID7. Neuronal–glial interactions play an important role in sensitizing and maintaining NP [50, 51]. In particular, Nam et al. showed that optogenetically induced spinal astrocyte activation governed the induction of pain hypersensitivity , while Gao et al. found that chemokine production in spinal cord astrocytes contributed to central sensitization of NP . Furthermore, Ji et al. reported that spinal microglia are important contributors to NP development after nerve injury, and several studies have found that inhibiting microglial activation reduces hyperalgesia after nerve damage [53, 54]. Taken together, these findings identify SCDH astrocytes and microglia as potential therapeutic targets for NP. Relevant to this important point, we demonstrated that 2-Hz and 20-Hz SNS significantly ameliorated L5 NRL-induced astrocytic gliosis and microglial activation. The suppression of glial cell activation is also consistent with our finding of decreased expression of inflammatory proteins in the spinal cord after 2-Hz and 20-Hz SNS. Together, these results demonstrate the efficacy of 2 Hz and especially 20-Hz SNS in reducing spinal cord neuroinflammation in the L5 NRL NP rat model. Furthermore, our results suggested 20-Hz SNS may exert a better anti-inflammatory efficacy in the spinal cord.
Importantly, we noted that the analgesic effect of SNS in the behavioral experiments occurred early on PID1, whereas the anti-inflammatory effect of SNS was not significant until PID7. In light of the different results between the behavioral experiments and biochemical analysis, we hypothesized that other anti-nociceptive mechanisms may be involved. Given that the PAG–RVM descending pain modulation pathway is an early responder to pain and the RVM is activated 30 min after exposure to noxious stimuli , we hypothesized that descending pain modulation may contribute to the analgesic effect of SNS on PID1. Serotonin (5-HT) is the major neurotransmitter involved in pain modulation in the RVM and the descending serotonergic pathways mainly originate from the 5-HT rich RMg [56, 57]. Activation of this descending serotoninergic pathway has been shown to attenuate both mechanical and thermal hyperalgesia [56, 58]. As predicted, our results revealed that 2-Hz and 20-Hz SNS induced increased activity of serotoninergic neurons located at the RMg of the RVM on PID1. Early activation of the RVM descending pain modulation pathway could explain the reduced pain and thermal hypersensitivity behavioral test results on PID1.
Furthermore, our results showed that while the differences in the level of spinal cord IL-1β and IL-6 between L5 NRL rats with and without SNS were not significant on PID1, 2-Hz and 20-HZ SNS were able to attenuate the increased expression of spinal cord IL-1β and IL-6 on PID7. A reasonable explanation to this finding is the early resolution of neuroinflammation [20, 59]. Since neuroinflammation is a major contributor of central pain sensitization and central sensitization plays an important role in the formation of NP, early treatment with neuromodulatory techniques is proposed to have an additional advantage to block pain-induced maladaptive plasticity and neuroinflammation following neuronal injury, thereby preventing the acute-to-chronic pain transitioning [60, 61]. As a result, the therapeutic effect of early SNS treatment is likely a combination of increased descending pain inhibition, decreased and early-resolved neuroinflammation, and attenuated central pain sensitization .
Taken together, these results suggest that 2-Hz and 20-Hz SNS are effective in alleviating acute NP following L5 NRL in a rat model by suppressing SCDH neuroinflammation and facilitating descending pain inhibition. Comparisons between different stimulation frequencies suggest a neuromodulatory role of 2-Hz and 20-Hz SNS compared to the paresthesia effect of 60 Hz. Furthermore, our results demonstrate better efficacy of 20 Hz compared to 2 Hz for suppressing neuroinflammation and facilitating descending pain inhibition.
This study is subject to several limitations. Although we demonstrated the efficacy of SNS as a treatment for NP, the exact molecular mechanism of electrical peripheral neurostimulation has not been explored. Next, the timing of when SNS is performed may be less clinically applicable. Since this pilot study aimed to validate the potential therapeutic effect of SNS on NP and identify the optimal frequency, we performed SNS 2 h after L5 NRL. Future studies should investigate the optimal timing of SNS following injury to alleviate acute NP. Understanding the basis of these processes may provide insight to improve the currently available neurostimulation techniques to achieve better patient satisfaction. In-depth knowledge about the pathobiology of NP and the responses of neural–glial interactions to PNS may reveal additional therapeutic targets.
In conclusion, our work has shown the analgetic effect of 2-Hz and 20-Hz SNS in an acute NP rodent model. We demonstrated regulation of inflammatory protein expression, astrocytic gliosis, and microglia activation following 2-Hz and 20-Hz SNS. During the early post-injury period, SNS might facilitate the descending pain modulatory pathway. Overall, our work has provided new insights into the cellular mechanisms of SNS and demonstrated its beneficial effect in acute NP.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Central nervous system
National Cheng Kung University
Nerve root ligation
Peripheral nerve stimulation
Raphe magnus nucleus
Spinal cord dorsal horn
Spinal cord stimulation
Sciatic nerve stimulation
Transcutaneous electrical nerve stimulation
Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci. 2009;32(1):1–32. https://doi.org/10.1146/annurev.neuro.051508.135531.
Ho Kim S, Mo CJ. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 1992;50(3):355–63. https://doi.org/10.1016/0304-3959(92)90041-9.
Wang LX, Wang ZJ. Animal and cellular models of chronic pain. Adv Drug Deliv Rev. 2003;55(8):949–65. https://doi.org/10.1016/S0169-409X(03)00098-X.
Yam M, Loh Y, Tan C, Khadijah Adam S, Abdul Manan N, Basir R. General pathways of pain sensation and the major neurotransmitters involved in pain regulation. Int J Mol Sci. 2018;19(8):2164. https://doi.org/10.3390/ijms19082164.
Ji RR, Nackley A, Huh Y, Terrando N, Maixner W. Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology. 2018;129(2):343–66. https://doi.org/10.1097/ALN.0000000000002130.
Ellis A, Bennett DLH. Neuroinflammation and the generation of neuropathic pain. Br J Anaesth. 2013;111(1):26–37. https://doi.org/10.1093/bja/aet128.
Xu M, Bruchas MR, Ippolito DL, Gendron L, Chavkin C. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by opioid activation of p38 mitogen-activated protein kinase. J Neurosci. 2007;27(10):2570–81. https://doi.org/10.1523/JNEUROSCI.3728-06.2007.
Zhuang ZY, Gerner P, Woolf CJ, Ji RR. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain. 2005;114(1):149–59. https://doi.org/10.1016/j.pain.2004.12.022.
Nam Y, Kim JH, Kim JH, et al. Reversible induction of pain hypersensitivity following optogenetic stimulation of spinal astrocytes. Cell Rep. 2016;17(11):3049–61. https://doi.org/10.1016/j.celrep.2016.11.043.
Jha MK, Jeon S, Suk K. Glia as a link between neuroinflammation and neuropathic pain. Immune Network. 2012;12(2):41. https://doi.org/10.4110/in.2012.12.2.41.
Cavalli E, Mammana S, Nicoletti F, Bramanti P, Mazzon E. The neuropathic pain: an overview of the current treatment and future therapeutic approaches. Int J Immunopathol Pharmacol. 2019;33:205873841983838. https://doi.org/10.1177/2058738419838383.
Sator-Katzenschlager S, Fiala K, Kress HG, et al. Subcutaneous target stimulation (STS) in chronic noncancer pain: a nationwide retrospective study. Pain Pract. 2010;10(4):279–86. https://doi.org/10.1111/j.1533-2500.2009.00351.x.
Gilmore CA, Kapural L, McGee MJ, Boggs JW. Percutaneous peripheral nerve stimulation for chronic low back pain: prospective case series with 1 year of sustained relief following short-term implant. Pain Pract. 2020;20(3):310–20. https://doi.org/10.1111/papr.12856.
Deer TR, Gilmore CA, Desai MJ, et al. Percutaneous peripheral nerve stimulation of the medial branch nerves for the treatment of chronic axial back pain in patients after radiofrequency ablation. Pain Med. 2021;22(3):548–60. https://doi.org/10.1093/pm/pnaa432.
Goebel A, Lewis S, Phillip R, Sharma M. Dorsal root ganglion stimulation for complex regional pain syndrome (CRPS) recurrence after amputation for CRPS, and failure of conventional spinal cord stimulation. Pain Pract. 2018;18(1):104–8. https://doi.org/10.1111/papr.12582.
Gabriel RA, Swisher MW, Ilfeld BM. Percutaneous peripheral nerve stimulation for acute postoperative pain. Pain Manage. 2019;9(4):347–54. https://doi.org/10.2217/pmt-2018-0094.
Ilfeld BM, Ball ST, Gabriel RA, et al. A feasibility study of percutaneous peripheral nerve stimulation for the treatment of postoperative pain following total knee arthroplasty. Neuromodulation. 2019;22(5):653–60. https://doi.org/10.1111/ner.12790.
Rosellini W, Casavant R, Engineer N, et al. Wireless peripheral nerve stimulation increases pain threshold in two neuropathic rat models. Exp Neurol. 2012;235(2):621–6. https://doi.org/10.1016/j.expneurol.2012.03.016.
Sluka KA, Walsh D. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J Pain. 2003;4(3):109–21. https://doi.org/10.1054/jpai.2003.434.
Lin T, Gargya A, Singh H, Sivanesan E, Gulati A. Mechanism of peripheral nerve stimulation in chronic pain. Pain Med. 2020;21:S6–12. https://doi.org/10.1093/pm/pnaa164.
Gürgen SG, Sayın O, Çetin F, Tuç YA. Transcutaneous electrical nerve stimulation (TENS) accelerates cutaneous wound healing and inhibits pro-inflammatory cytokines. Inflammation. 2014;37(3):775–84. https://doi.org/10.1007/s10753-013-9796-7.
Torebjork HE, Hallin RG. Responses in human A and C fibres to repeated electrical intradermal stimulation. J Neurol Neurosurg Psychiatry. 1974;37(6):653–64. https://doi.org/10.1136/jnnp.37.6.653.
Kim YJ, Lee SG, Go SJ, et al. Anti-inflammatory effects of low-frequency stimulator using superposition of alternating microcurrent wave in the animal models. Biomed Sci Lett. 2021;27(2):99–104. https://doi.org/10.15616/BSL.2021.27.2.99.
Ilfeld BM, Grant SA, Gilmore CA, et al. Neurostimulation for postsurgical analgesia: a novel system enabling ultrasound-guided percutaneous peripheral nerve stimulation. Pain Pract. 2017;17(7):892–901. https://doi.org/10.1111/papr.12539.
Huang YG, Zhang Q, Wu H, Zhang CQ. A comparison of surgical invasions for spinal nerve ligation with or without paraspinal muscle removal in a rat neuropathic pain model. Biomed Res Int. 2016;2016:1–8. https://doi.org/10.1155/2016/6741295.
Kanbar R, Stornetta RL, Guyenet PG. Sciatic nerve stimulation activates the retrotrapezoid nucleus in anesthetized rats. J Neurophysiol. 2016;116(5):2081–92. https://doi.org/10.1152/jn.00543.2016.
Peirs C, Dallel R, Todd AJ. Recent advances in our understanding of the organization of dorsal horn neuron populations and their contribution to cutaneous mechanical allodynia. J Neural Transm. 2020;127(4):505–25. https://doi.org/10.1007/s00702-020-02159-1.
Kawasaki Y, Zhang L, Cheng JK, Ji RR. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1, interleukin-6, and tumor necrosis factor- in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci. 2008;28(20):5189–94. https://doi.org/10.1523/JNEUROSCI.3338-07.2008.
Sung B, Lim G, Mao J. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci. 2003;23(7):2899–910. https://doi.org/10.1523/JNEUROSCI.23-07-02899.2003.
Gao YJ, Ji RR. Targeting astrocyte signaling for chronic pain. Neurotherapeutics. 2010;7(4):482–93. https://doi.org/10.1016/j.nurt.2010.05.016.
Coull JAM, Beggs S, Boudreau D, et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature. 2005;438(7070):1017–21. https://doi.org/10.1038/nature04223.
Ulmann L, Hatcher JP, Hughes JP, et al. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J Neurosci. 2008;28(44):11263–8. https://doi.org/10.1523/JNEUROSCI.2308-08.2008.
Guan Y, Yuan F, Carteret AF, Raja SN. A partial L5 spinal nerve ligation induces a limited prolongation of mechanical allodynia in rats: an efficient model for studying mechanisms of neuropathic pain. Neurosci Lett. 2010;471(1):43–7. https://doi.org/10.1016/j.neulet.2010.01.006.
Gray P. Acute neuropathic pain: diagnosis and treatment. Curr Opin Anaesthesiol. 2008;21(5):590–5. https://doi.org/10.1097/ACO.0b013e32830c900c.
Przewłocka B, Mika J, Łabuz D, Toth G, Przewłocki R. Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats. Eur J Pharmacol. 1999;367(2–3):189–96. https://doi.org/10.1016/S0014-2999(98)00956-X.
Ulloa L, Quiroz-Gonzalez S, Torres-Rosas R. Nerve stimulation: immunomodulation and control of inflammation. Trends Mol Med. 2017;23(12):1103–20. https://doi.org/10.1016/j.molmed.2017.10.006.
Szolcsányi J, Helyes Z, Oroszi G, Németh J, Pintér E. Release of somatostatin and its role in the mediation of the anti-inflammatory effect induced by antidromic stimulation of sensory fibres of rat sciatic nerve. Br J Pharmacol. 1998;123(5):936–42. https://doi.org/10.1038/sj.bjp.0701685.
Pavlov VA, Tracey KJ. The vagus nerve and the inflammatory reflex—linking immunity and metabolism. Nat Rev Endocrinol. 2012;8(12):743–54. https://doi.org/10.1038/nrendo.2012.189.
Caravaca AS, Gallina AL, Tarnawski L, et al. An effective method for acute vagus nerve stimulation in experimental inflammation. Front Neurosci. 2019. https://doi.org/10.3389/fnins.2019.00877.
Tu L, Gharibani P, Zhang N, Yin J, Chen JD. Anti-inflammatory effects of sacral nerve stimulation: a novel spinal afferent and vagal efferent pathway. Am J Physiol Gastrointest Liver Physiol. 2020;318(4):G624–34. https://doi.org/10.1152/ajpgi.00330.2019.
Buwembo J, Munson R, Rizvi SA, Ijaz A, Gupta S. Direct sciatic nerve electrical stimulation for complex regional pain syndrome type 1. Neuromodulation. 2021;24(6):1075–82. https://doi.org/10.1111/ner.13294.
Carbonario F, Matsutani LA, Yuan SLK, Marques AP. Effectiveness of high-frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. Eur J Phys Rehabil Med. 2013;49(2):197–204.
Banks GP, Winfree CJ. Evolving techniques and indications in peripheral nerve stimulation for pain. Neurosurg Clin N Am. 2019;30(2):265–73. https://doi.org/10.1016/j.nec.2018.12.011.
Saranya B, Ahmed J, Shenoy N, Ongole R, Sujir N, Natarajan S. Comparison of transcutaneous electric nerve stimulation (TENS) and microcurrent nerve stimulation (MENS) in the management of masticatory muscle pain: a comparative study. Pain Res Manage. 2019;2019:1–5. https://doi.org/10.1155/2019/8291624.
Lees JG, Duffy SS, Moalem-Taylor G. Immunotherapy targeting cytokines in neuropathic pain. Front Pharmacol. 2013. https://doi.org/10.3389/fphar.2013.00142.
Murphy P, Grondin J, Altares M, Richardson P. Induction of interleukin-6 in axotomized sensory neurons. J Neurosci. 1995;15(7):5130–8. https://doi.org/10.1523/JNEUROSCI.15-07-05130.1995.
Costigan M, Moss A, Latremoliere A, et al. T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity. J Neurosci. 2009;29(46):14415–22. https://doi.org/10.1523/JNEUROSCI.4569-09.2009.
Okamoto K, Martin DP, Schmelzer JD, Mitsui Y, Low PA. Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp Neurol. 2001;169(2):386–91. https://doi.org/10.1006/exnr.2001.7677.
Whitehead KJ, Smith CGS, Delaney SA, et al. Dynamic regulation of spinal pro-inflammatory cytokine release in the rat in vivo following peripheral nerve injury. Brain Behav Immun. 2010;24(4):569–76. https://doi.org/10.1016/j.bbi.2009.12.007.
Gwak YS, Hulsebosch CE, Leem JW. Neuronal-glial interactions maintain chronic neuropathic pain after spinal cord injury. Neural Plast. 2017;2017:1–14. https://doi.org/10.1155/2017/2480689.
Ji RR, Berta T, Nedergaard M. Glia and pain: Is chronic pain a gliopathy? Pain. 2013;154(Supplement 1):S10–28. https://doi.org/10.1016/j.pain.2013.06.022.
Gao YJ, Zhang L, Samad OA, et al. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci. 2009;29(13):4096–108. https://doi.org/10.1523/JNEUROSCI.3623-08.2009.
von Hehn CA, Baron R, Woolf CJ. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron. 2012;73(4):638–52. https://doi.org/10.1016/j.neuron.2012.02.008.
Clark AK, Gentry C, Bradbury EJ, McMahon SB, Malcangio M. Role of spinal microglia in rat models of peripheral nerve injury and inflammation. Eur J Pain. 2007;11(2):223–30. https://doi.org/10.1016/j.ejpain.2006.02.003.
Tobaldini G, Sardi NF, Guilhen VA, Fischer L. Pain inhibits pain: an ascending-descending pain modulation pathway linking mesolimbic and classical descending mechanisms. Mol Neurobiol. 2019;56(2):1000–13. https://doi.org/10.1007/s12035-018-1116-7.
Ossipov MH, Dussor GO, Porreca F. Central modulation of pain. J Clin Investig. 2010;120(11):3779–87. https://doi.org/10.1172/JCI43766.
Lv Q, Wu F, Gan X, et al. The involvement of descending pain inhibitory system in electroacupuncture-induced analgesia. Front Integr Neurosci. 2019. https://doi.org/10.3389/fnint.2019.00038.
Sasaki M, Obata H, Kawahara K, Saito S, Goto F. Peripheral 5-HT2A receptor antagonism attenuates primary thermal hyperalgesia and secondary mechanical allodynia after thermal injury in rats. Pain. 2006;122(1):130–6. https://doi.org/10.1016/j.pain.2006.01.021.
Ji RR, Xu ZZ, Gao YJ. Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov. 2014;13(7):533–48. https://doi.org/10.1038/nrd4334.
Bazzari AH, Bazzari FH. Advances in targeting central sensitization and brain plasticity in chronic pain. Egypt J Neurol Psychiatry Neurosurg. 2022;58(1):38. https://doi.org/10.1186/s41983-022-00472-y.
Andrade DC, Borges I, Bravo GL, Bolognini N, Fregni F. Therapeutic time window of noninvasive brain stimulation for pain treatment: inhibition of maladaptive plasticity with early intervention. Expert Rev Med Devices. 2013;10(3):339–52. https://doi.org/10.1586/erd.12.90.
This work was supported by National Cheng Kung University Hospital (NCKUH-11001004).
Ethics approval and consent to participate
This study was approved by the Animal Ethics Committee of NCKU in Tainan, Taiwan (IACUC approval number: 109195). All surgical interventions, perioperative care, and treatments were performed in accordance with the guidelines of the Institute of Animal Use and Care Committee at NCKU.
Consent for publication
W. Liu holds shareholder interest in Niche Biomedical Inc. The other authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Wong, CE., Hu, CY., Lee, PH. et al. Sciatic nerve stimulation alleviates acute neuropathic pain via modulation of neuroinflammation and descending pain inhibition in a rodent model. J Neuroinflammation 19, 153 (2022). https://doi.org/10.1186/s12974-022-02513-y
- Sciatic nerve stimulation
- Peripheral nerve stimulation
- Neuropathic pain
- Nerve root ligation
- Descending pain inhibition